Punjab Samachar

Acute Ischemic Stroke Market Is Expected To Grow During The Study Period (2019-2032), DelveInsight | Key Players- Genentech, Athersys, and Others

 Breaking News
  • No posts were found

Acute Ischemic Stroke Market Is Expected To Grow During The Study Period (2019-2032), DelveInsight | Key Players- Genentech, Athersys, and Others

September 16
04:08 2022
Acute Ischemic Stroke Market Is Expected To Grow During The Study Period (2019-2032), DelveInsight | Key Players- Genentech, Athersys, and Others

“The increase in Acute Ischemic Stroke Market size is a direct consequence of an increase in R& D activity, increasing prevalent population, expected commercial success of upcoming therapies in the 7MM”

 

The Acute Ischemic Stroke Market is expected to gain market growth in the forecast period of 2022 to 2032. The growing cases of tumors will directly impact the growth of the Acute Ischemic Stroke Market.

 

The Acute ischemic stroke market report provides current treatment practices, emerging drugs, acute ischemic stroke market share of the individual therapies, and current and forecasted acute ischemic stroke market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current acute ischemic stroke treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Acute ischemic stroke market.

 

Key takeaways from the Acute Ischemic Stroke Market Research Report

  • The potential Acute ischemic stroke (AIS) drugs recently launched in the Acute ischemic stroke (AIS) market or expected to get launched in the market during the study period 2019-2032
  • According to the World Health Organization (WHO), an estimated 15 million individuals worldwide suffer from stroke each year. Of these, 5 million die, and another 5 million are left permanently disabled.
  • As per the study conducted by Amy Guzik et. al. titled “Stroke Epidemiology and Risk Factor Management”, 2017, approximately 85% of strokes are ischemic. While ischemic strokes are more common in men than women when young and middle-aged, women have a higher lifetime risk of stroke than men (20% to 21% versus 14% to 17%) with poorer functional outcomes.
  • Acute Ischemic Stroke market companies included Genentech, Athersys, and many others
  • Acute Ischemic Stroke market therapies included Activase, MultiStem, and many others

 

Interested to know more about the ongoing developments in the Acute Ischemic Stroke Market Outlook? Visit here- Acute Ischemic Stroke Market Size

 

Acute Ischemic Stroke Overview

Acute Ischemic Stroke occurs when blood flow through a brain artery is blocked by a clot- a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop within the body. A thrombotic stroke, more common of the two, occurs when a clot forms within an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from elsewhere in the body, such as the heart, and travels through the bloodstream only to become stuck in a narrower vessel in the brain.

 

Acute Ischemic Stroke Epidemiology

The Acute Ischemic Strokeepidemiology section covers insights into the historical and current Acute Ischemic Stroke patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.

 

Acute Ischemic Stroke Market Dynamics

The Acute Ischemic Stroke market dynamics are anticipated to change in the coming years, owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and the expected launch of emerging therapies during the forecast period. Companies across the globe are working towards the development of new treatment therapies for Acute Ischemic Stroke. Key players, such as Athersys, Abbvie, Bristol-Myers Squibb, Lumosa Therapeutics, Teijin Pharma Limited, etc. are involved in developing drugs for AIS.

 

Discover more relevant information on the Acute Ischemic Stroke Market Research Report here- Acute Ischemic Stroke Market Share

 

Acute Ischemic Stroke Treatment Market

Even though various treatment options are available, still there are many limitations. Current drug treatments are problematic because of their small therapeutic window and higher risk of hemorrhage. Current treatments still leave several AIS patients with disabling symptoms after having a stroke, which remains one of the major unmet needs in AIS management. So, all these factors create an urgent demand for novel therapies that can treat the root cause of Acute Ischemic Stroke and can overcome the adverse effects of existing therapies.

 

Acute Ischemic Stroke Therapeutics Market

The Acute Ischemic Stroke Therapeutic Market can be primarily divided into two main categories based on their mechanism of action: thrombolytics and neuroprotective agents. Thrombolytic therapy aims at removing the thrombus blockage and includes drugs that act as recombinant tissue plasminogen activators (rt-PA), antithrombotic agents, and platelet aggregation inhibitors.

 

Acute Ischemic Stroke Market Landscape

The Acute Ischemic Stroke market size is anticipated to increase during the study period owing to the increasing incident population and rising awareness of Acute Ischemic Stroke in the 7MM. The expected launch of emerging therapies and the research and development activities of pharmaceutical companies will also fuel the market growth during the forecast period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Acute Ischemic Stroke market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Acute Ischemic Stroke market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

 

Read more about the Acute Ischemic Stroke Market Companies and Therapies in the report- Acute Ischemic Stroke Market Companies

 

Scope of the Acute Ischemic Stroke Market Forecast Report

  • Coverage- 7MM
  • Study Period- 2019-2032
  • Acute Ischemic Stroke MarketForecast Period- 2022-2032
  • Acute Ischemic Stroke Market companies included Genentech, Athersys, and many others
  • Acute Ischemic Stroke Market therapies included Activase, MultiStem, and many others
  • Acute Ischemic Stroke Market Drivers and Barriers
  • KOL Views
  • Acute Ischemic Stroke Market Access and Reimbursement

 

Table of content

  1. Key Insights
  2. Executive Summary
  3. Competitive Intelligence Analysis
  4. Acute Ischemic Stroke Market Overview at a Glance
  5. Disease Background and Overview
  6. Patient Journey
  7. Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Unmet Needs
  10. Key Endpoints of Acute Ischemic Stroke Treatment
  11. Acute Ischemic Stroke Marketed Products
  12. Acute Ischemic Stroke Emerging Therapies
  13. Seven Major Acute Ischemic Stroke Market Analysis
  14. Attribute analysis
  15. 7MM: Acute Ischemic Stroke Market Outlook
  16. Access and Reimbursement Overview
  17. KOL Views
  18. Acute Ischemic Stroke Market Drivers
  19. Acute Ischemic Stroke Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

 

Got queries? Reach out for more details on the Acute Ischemic Stroke Market Forecast Report- https://www.delveinsight.com/sample-request/acute-ischemic-stroke-ais-market

 

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Categories